Background: Chronic steroids represent treatment options for many chronic diseases, but predispose
to both weight gain and surgical complications. They therefore represent a unique
interface between obesity, chronic disease, and surgical risk. As the benefits of
bariatric surgery for controlling metabolic disease become more apparent, patients
with chronic illnesses on corticosteroids are increasingly being referred for surgery
despite an unclear safety profile. The Metabolic and Bariatric Surgery Accreditation
Quality Improvement Program (MBSAQIP) database represents the largest bariatric-specific
clinical dataset for comparing outcomes in this complex patient population.
To read this article in full you will need to make a payment
© 2018 Published by Elsevier Inc.